Avermectins in arthropod vector management - prospects and pitfalls.
The proven impact of avermectins against a wide variety of arthropod vectors suggests that this new family of compounds holds promise in reducing the incidence of vector-borne disease. Experimentally, decreased survival and abundance of various vector species indicate that certain vector populations may be so manipulated. In addition, sublethal effects on individuals include lengthened development, decreased fecundity and diminished parasite uptake. Enthusiasm must be cautious, given possible impacts on non-target species and the eventual development of resistance. Here Mark Wilson emphasizes that the present challenge is to study how this new toxin may be integrated into vector-management schemes that already employ multiple, diverse interventions. Ultimately, the value of such action must be measured not simply in terms of reduced vector abundance, but also with the more complex equation of reduced parasite transmission in mind.
Yale Arbovirus Research Unit, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06510, USA.
M L
ML
Wilson